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Letters Re: "Cyclosiloxanes
Produce Fatal Liver and Lung
Damage in Mice"
It is EHPs stated editorial policy to serve
as a forum for discussion ofissues ofenvi-
ronmental health, encouraging the expres-
sion of scientific opinion and fostering
healthy scientific debate. Your editorial
policy states that "all scientific articles are
subject to rigorous peer review. The prima-
ry criteria are environmental significance
and scientific quality." Based on these cri-
teria, it appears that the journal has failed
to hold the paper ofLieberman et al. (1) to
these standards. This paper is a blatant and
deliberate misdirection of the reader, pro-
viding misinterpretation of a poorly
designed study that is not up to the stan-
dards ofmodern toxicology or EHP.
Lieberman et al. (1) indicate that they
distilled breast implant gel at 180°C at
reduced pressure for 24 hr and imply that
this material represents what would leak
from implants. It is well known that silicone
polymers can thermally depolymerize to
form cyclic siloxanes under the authors' dis-
tillation conditions (2), but this does not
represent "real life" conditions. Lieberman et
al. (1) administered this distillate to mice by
intraperitoneal (ip) injection at doses up to
35,000 mg/kg-surely an unacceptablyhigh
dose that would cause direct irritation. It is
therefore no surprise that the identified ip
median lethal dose (LD 0) was 28,000
mg/kg and that lung and iver lesions were
noted. Perhaps the animal care committee
should have requested a revision ofthe test-
ing protocol before the study was initiated.
Lieberman et al. (1) reported that one ofthe
individual components of the distillate,
identified as CS-4 based on an ip LD50 of
6,000-7,000 mg/kg, is equivalent in toxicity
to oral exposures to carbon tetrachloride;
they characterized the distillate and individ-
ual distillate materials as highly toxic. For
regulatory purposes, any material with an
LD50 greater than 2,000 mg/kg (3) or 5,000
mg/kg (4-9) is considered to be the highest
dose necessary to test. Materials with LD50
values greater than these dose levels are con-
sidered to bevirtually nontoxic.
Ifthis misinterpretation oftoxicity data
were to remain quietly in the annals of
EHP, it would be merely a problem ofedi-
torial carelessness. However, this paper has
been picked up by several of the news ser-
vices (e.g., Reuters, BBC), with online and
print mediadeclaring "Silicones Kill Mice!"
and no longer noting that the dose and
dose route are responsible for the lethality,
not the inherent toxicity ofthe material. By
publishing this paper, EHP has become a
source for junk science reporters. The fact
that the NIEHS is a well-respected scientif-
ic body only adds more credence to this ill-
conceived and misinterpreted study.
I implore you be more attentive to the
content ofthe articles published in EHP. It
weakens the reputation of the NIEHS,
feeds the junk science machine, and dimin-
ishes the credibility of all toxicologists
when articles such as this are given space in
a peer-reviewed scientific journal.
Betsy D. Carlton
Chemicals Toxicology
Rhodia Inc.
Raleigh, North Carolina
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In the February issue ofEHP, Lieberman et
al. (1) reported that the intraperitoneal (ip)
injection ofeither cyclosiloxanes (CSs) from
silicone breast implant distillate or CS-D4,
a component of breast implant distillate,
was lethal and caused liver and lung damage
and increased hydroxyl radical formation.
This paper is flawed and contains a number
ofscientific issues that need to be addressed.
Lieberman et al. (1) reported that a dis-
tillate from an explanted breast implant
contains anywhere from 2 to 60%
cyclosiloxanes, with CS-D4 being present at
the highest concentration. It is well known
that destructive distillation of a siloxane
polymer or gel at high temperature under
vacuum "cracks" the polymer causing,
under these destructive conditions, the for-
mation of large amounts ofcyclosiloxanes
(2). There is no doubt that the low molecu-
lar weight cyclosiloxanes collected by
Lieberman et al. (1) were created during the
distillation by a "cracking" process. The
conditions required to crack a polymer do
not exist in the human body. Our own
analysis of an intact silicone breast implant
shows that CS-D4 levels rarely, if ever,
exceed approxmately 700 ppm (i.e., 700
pg/g). Migration ofCS-D4 from an implant
occurs at a rate of about 0.58 pg/day (3)
which, for a 60-kg women, equates to a
0.010 pg/kg/dayexposure to CS-D4.
Lieberman et al. (1) reported that after
a single subcutaneous injection in mice of
250 mg (or about 10 g/kg body weight) of
breast implant distillate, the cyclosiloxanes
are widely distributed to many organs and
can be detected as much as 1 year following
a single injection. In their original paper
(4), many of the values reported for tissue
concentrations ofcyclosiloxanes at 9 weeks
and later appeared to be at or below the
limit of detection of their analytical
methodology and were well below what
would be considered the limit ofquantita-
tion, making some of their conclusions
misleading. In our own studies (5-2) using
14C-CS-D4 administration to rats by vari-
ous routes ofexposure, we also showed that
CS-D4 was uniformly distributed to tis-
sues, but with an elimination half-life of
parent and metabolites of 50-200 hr,
depending on the tissue, and < 0.0078% of
the radioactivity left in tissues at 6 weeks
postexposure. These data indicate that it is
unlikely that CS-D4 would be found in tis-
sues 1 year afteradministration.
As for the acute toxicity effects reported
by Lieberman et al. (1), many ofthe report-
ed findings oppose the conventional wis-
dom oftoxicology. Administration ofup to
1 mL ofa substance into the peritoneal cav-
ity ofa 25-30-g mouse (which is equivalent
to 2.4 L injected into the abdominal cavity
of a human) basically represents the maxi-
mum dose that can be administered to a
mouse and far exceeds the dose ofCSs that
could be encountered byhumans under any
condition, including women with breast
implants. The LD50 values of-28 g/kg and
6-7 g/kg reported by Lieberman et al. (1)
for the distillate and CS-D4, respectively,
were used to indicate extreme toxicity,
which is absurd. Credible references in toxi-
cology (8,9) would consider compounds
with acute LD50 values of 5-15 g/kg to be
practically nontoxic, whereas compounds
with LD50 values of > 15 g/kg are consid-
ered relatively harmless. Based on the data
presented by Lieberman et al. (1) and using
these widely accepted criteria, one should
interpret that CS-D4 is practically nontoxic
and the inappropriately prepared breast
implant distillate is relatively harmless.
Lieberman et al. (1) further suggest that by
comparing ip LD50 values to the oral LD50
values of carbon tetrachloride and
trichloroethylene, "the value for CS-D4
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indicates that this compound exhibits toxic-
ity comparable to these other agents."
Conventional toxicity tables (8,9) compar-
ing LD50 values show that the ip LD for
sodium chloride is 4 g/kg. Thus, ordinary
table salt is more toxic than either CS-D4
or breast implant distillate! To further put
this into perspective relative to silicone
breast implants, it would take about two
660-pound breast implants in an average
size women to achieve a dose equivalent to
the LD50 reported for CS-D4 byLieberman
et al. (1). This is based on the unrealistic
assumption that all of the CS-D4 in an
implantwould be released at one time.
The histopathologic findings reported
by Lieberman et al. (1) are an enigma.
Tables 2 and 3 in their paper show the
reported histopathologic changes and aver-
age grade of the reported lesions for
implant distillate and CS-D4, respectively.
The findings reported in these tables are
clearly not dose related. For example, in
Table 2 (1), the highest incidence (3 of 6
animals) ofextensive necrosis was produced
by the lowest dose (3.5 g/kg), which had
the lowest incidence (1 of 6 animals) of
individual cell necrosis. Conversely, a dose
of35 g/kg had a 1-of-6 incidence ofexten-
sive necrosis and a 5-of-6 incidence ofindi-
vidual cell necrosis. Further, the increases
reported by Lieberman et al. (1) for the
three liver enzymes (Figure 3A and B) are
minimal, relative to the high doses admin-
istered, and do not appear to be dose relat-
ed. There is no indication in the figures
that the observed values are statistically sig-
nificantly different from control. Statistical
significance is difficult to determine from
examination of the figures because of the
tremendous variability and the fairly consis-
tent or uniform response across all the
doses. The observation in this study that
death of the animals occurred 5-8 days
after the ip injections ofeither distillate or
CS-D4 indicates that death was not due to
a direct toxic effect of the test materials.
The delayed deaths are consistent with an
infectious process probably related to the
quality of the test material or to a highly
inflammatory process related to the route
and volume of test material administered
with a resultant peritonitis. It is perplexing
that Lieberman et al. (1) apparently did not
perform a microbiologic assessment on the
test material or the animals at necropsy to
rule out an infectious process. Certainly the
apparent increase in free radical formation
can be associated with an inflammatory
response. It is also noteworthy that, in the
study to assess free radical formation, the
dose of CS-D4 administered was greater
than the reported LD50 for this compound
by this route.
Lieberman et al. (l)state in their dis-
cussion section that
We have no evidence that these compounds are
metabolized, but it is clear they evoke strong bio-
logical responses.
This is in marked contrast to all of the
available literature. Studies by McKim et al.
(10) clearly show that CS-D4 induces
cytochrome P450 2B1/B2 in rats in a time,
dose-dependent, and "phenobarbital-like"
manner. In other words, it is an adaptive
effect. Studies conducted by Plotzke et al.
(5-7) and Varaprath et al. (11) provide
compelling evidence that CS-D4 (and
probably other cyclosiloxanes) are exten-
sively metabolized by rats and that metabo-
lism and subsequent elimination of
hydrophilic metabolites in urine and feces
is an important clearance mechanism from
mammalian species. In particular, the rates
ofmetabolism and clearance ofCS-D4 and
its metabolites (5,6) suggest that these com-
pounds will not be unusually persistent in
mammalian organisms and are inconsistent
with the suggestion by Lieberman et al. (1)
that these compounds will persist in mice
for "at least ayear..." in a number oforgans
and fat.
In summary, this paper [Lieberman et
al. (1)] is deficient in several areas including
data interpretation, review of existing and
relevant research, and application of basic
toxicology principles. The authors have
ignored the central paradigm of toxicology
as put forth by Paracelsus (12), which, as
paraphrased, states "the dose makes the poi-
son." Judge Sam C. Pointer, Jr., the federal
judge overseeing the multidistrict breast
implant litigation, appointed an expert sci-
entific panel to review the available data on
breast implants. Their toxicology review
"reaffirmed the low systemic toxicity ofsili-
cone" (13). The data ofLieberman et al. (1)
(contrary to the authors' interpretations)
also reaffirm this conclusion oflow systemic
toxicity. Although the authors acknowledge
funding from Consumer Advocates for
Product Safety (CAPS), they fail to note
that funding for CAPS is obtained through
attorneys for plaintiffs in the breast implant
litigation.
Robert G. Meeks
Toxicology and RiskAssessment
Dow Corning Corporation
Midland, Michigan
E-mail: robert.meeks@dowcorning.com
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In the February issue of EHP, Lieberman
et al. (1) published an interesting study on
the toxicity of cyclosiloxanes. Briefly, they
intraperitoneally injected mice with a
breast implant distillate consisting of a
mixture ofcyclosiloxanes. After 4-14 days,
they performed histopathologic studies and
measured the formation of hydroxyl radi-
cal and levels of serum enzymes. The
experiments are well done and the observa-
tions that were made are certainly believ-
able. However, I am somewhat puzzled by
the way the findings are interpreted. In
several places Lieberman et al. stated that
these compounds [i.e., hexamethylcy-
clotrisiloxane (D3), octamethylcyclote-
trasiloxane (D4), decamethylcyclopen-
tasiloxane (D5), and dodecamethylcyclo-
hexasiloxane (D6)] are highly toxic.
Furthermore, the authors quoted a previ-
ous study which apparently showed that
following a single subcutaneous injection,
cyclosiloxanes are "widely distributed"
throughout the body (2).
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